EU Anti-Terror Data Retention Directive Meeting Resistance In EU Courts 01/06/2013 by Intellectual Property Watch 1 Comment The European Court of Justice in a decision dated 30 May ordered Sweden to pay a lump sum of €3 million euros for its delay in transposing the controversial 2006 EU data retention directive into national law in time.
MPAA, US Blind Federation Urge Narrow Focus In WIPO Treaty For Blind 30/05/2013 by William New, Intellectual Property Watch 2 Comments The US film industry and advocates for the blind joined forces today to urge World Intellectual Property Organization negotiators to keep treaty talks focussed on the core issue of making more books available to the blind and visually impaired. The joint statement appeared to be aimed at reining in stakeholders on both sides of the international debate.
Focus On Quality For Patients Saves Billions Of Dollars 27/05/2013 by Intellectual Property Watch Leave a Comment Daniela Bagozzi writes: Ten years of efforts in treatment for priority diseases has yielded impressive results both in terms of lives and dollars saved. To maintain progress in a volatile and financially tight environment countries and the international community will need to increase pressure on quality and healthy generic competition.
World Health Assembly: Drafting Group Agrees On Health R&D Meeting Proposal 25/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 1 Comment An informal drafting group finalised a text today, proposing to convene a technical meeting to help identify new health research and development projects for diseases that primarily affect poor communities.
At WTO, LDC Fight For Extension Of TRIPS Transition Continues 24/05/2013 by William New, Intellectual Property Watch 3 Comments Over the past week or so, least-developed country (LDC) members of the World Trade Organization have held their own in a closed room with the world’s biggest economies as they worked out details of a request by the LDCs to extend the deadline by which they must enforce WTO intellectual property rules.
World Health Assembly: Groups Seek To Return Focus To ‘Broken’ Medical R&D System 24/05/2013 by Brittany Ngo for Intellectual Property Watch and William New Leave a Comment The issue of access to medicines is on the agenda at this week’s World Health Assembly (WHA) and public health advocates are seeking greater clarity and detail about the latest member state effort to address failings in the global system of research and development for medical products.
EPO Still Granting Patents On Conventional Vegetables; ‘Just Following Rules’ 24/05/2013 by Catherine Saez, Intellectual Property Watch 4 Comments The European Patent Office is continuing to grant patents on conventional plants despite demands from the European Parliament and the German Parliament that the patent office refrain from granting such patents, the coalition of non-governmental organisations called “No patents on seeds” said in a release.
Parliament Members Call For Removal Of Conditions In WIPO Treaty For Blind 22/05/2013 by Monika Ermert for Intellectual Property Watch 4 Comments Members of all political party groups in the European Parliament in a debate in Strasbourg yesterday asked the European Commission to scrap several conditions demanded by the European Union and other Western countries in the World Intellectual Property Organization negotiations for the draft treaty on copyright exceptions for the blind and visually impaired.
WHO Stats Show Medicines Remain Out Of Reach Of Poorest Patients 15/05/2013 by Intellectual Property Watch 1 Comment While the World Health Organization’s latest health numbers show that great progress has been made in improving the health in low-income countries, significant inequalities remain between people living in the richest and poorest countries. Access to even the most basic medicines continues to be a major challenge due to high prices.
US Supreme Court Rules In Favour Of Monsanto In Patent Exhaustion Case 13/05/2013 by Catherine Saez, Intellectual Property Watch 4 Comments The United States Supreme Court found today that a farmer who buys patented seeds may not reproduce them through planting and harvesting without the right holder’s permission. The case, known as Bowman v. Monsanto, revolved around patent exhaustion. The Supreme Court was to decide whether patent exhaustion applied to patented seeds after their authorised sale.